Ebola
The Democratic Republic of the Congo, 2026
Overview
An Ebola outbreak was confirmed in the Democratic Republic of the Congo and in Uganda in May 2026. The Bundibugyo species of Ebola involved is one for which there is no vaccine or specific treatment, though work is ongoing to test promising candidates. The outbreak is occurring in a challenging context: humanitarian crisis and a remote and densely populated area, combined with insecurity and high population and trade movements. WHO is scaling up support to the governments of the Democratic Republic of the Congo and Uganda, strengthening surveillance, contact tracing, clinical preparedness and management, delivery of supplies and community engagement, and cross-border preparedness. Community engagement will be key. It is only when communities are engaged in the response that such outbreaks are bought under control.
More content on the website of the WHO African Region
News
Publications
WHO Technical Advisory Group on therapeutics prioritization for Bundibugyo virus disease: meeting report,...
This meeting report summarizes discussions of the WHO Research and Development (R&D) Blueprint Technical Advisory Group on Therapeutics Prioritization...
WHO Technical Advisory Group on candidate vaccine prioritization: meeting report, 19 and 25 May 2026
This meeting report summarizes the deliberations and recommendations of the WHO Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP)...
This emergency guidance document outlines the World Health Organization (WHO) position on the use of the licensed Ebola virus vaccine Ervebo® during...
WHO guidance for mass gathering events attended by individuals from areas with documented Bundibugyo...
This WHO guidance provides updated recommendations for the planning and management of mass gathering events attended by individuals from areas with documented...
Speeches
All →WHO Technical Advisory Group on therapeutics prioritization for Bundibugyo virus disease: meeting report,...
This meeting report summarizes discussions of the WHO Research and Development (R&D) Blueprint Technical Advisory Group on Therapeutics Prioritization...
WHO Technical Advisory Group on candidate vaccine prioritization: meeting report, 19 and 25 May 2026
This meeting report summarizes the deliberations and recommendations of the WHO Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP)...
This emergency guidance document outlines the World Health Organization (WHO) position on the use of the licensed Ebola virus vaccine Ervebo® during...
WHO guidance for mass gathering events attended by individuals from areas with documented Bundibugyo...
This WHO guidance provides updated recommendations for the planning and management of mass gathering events attended by individuals from areas with documented...
Photos